563 related articles for article (PubMed ID: 20032397)
21. Prognostic significance of STAT3 expression and its correlation with chemoresistance of non-small cell lung cancer cells.
Yin Z; Zhang Y; Li Y; Lv T; Liu J; Wang X
Acta Histochem; 2012 Feb; 114(2):151-8. PubMed ID: 21549414
[TBL] [Abstract][Full Text] [Related]
22. JAK2 tyrosine kinase inhibitor AG490 suppresses cell growth and invasion of gallbladder cancer cells via inhibition of JAK2/STAT3 signaling.
Fu LX; Lian QW; Pan JD; Xu ZL; Zhou TM; Ye B
J Biol Regul Homeost Agents; 2017; 31(1):51-58. PubMed ID: 28337870
[TBL] [Abstract][Full Text] [Related]
23. STAT3 interacts with Skp2/p27/p21 pathway to regulate the motility and invasion of gastric cancer cells.
Wei Z; Jiang X; Qiao H; Zhai B; Zhang L; Zhang Q; Wu Y; Jiang H; Sun X
Cell Signal; 2013 Apr; 25(4):931-8. PubMed ID: 23333463
[TBL] [Abstract][Full Text] [Related]
24. Autocrine IL-6-induced Stat3 activation contributes to the pathogenesis of lung adenocarcinoma and malignant pleural effusion.
Yeh HH; Lai WW; Chen HH; Liu HS; Su WC
Oncogene; 2006 Jul; 25(31):4300-9. PubMed ID: 16518408
[TBL] [Abstract][Full Text] [Related]
25. IL-6 Enhances Osteocyte-Mediated Osteoclastogenesis by Promoting JAK2 and RANKL Activity In Vitro.
Wu Q; Zhou X; Huang D; Ji Y; Kang F
Cell Physiol Biochem; 2017; 41(4):1360-1369. PubMed ID: 28278513
[TBL] [Abstract][Full Text] [Related]
26. IL-6 attenuates trimethyltin-induced cognitive dysfunction via activation of JAK2/STAT3, M1 mAChR and ERK signaling network.
Kim BK; Tran HY; Shin EJ; Lee C; Chung YH; Jeong JH; Bach JH; Kim WK; Park DH; Saito K; Nabeshima T; Kim HC
Cell Signal; 2013 Jun; 25(6):1348-60. PubMed ID: 23499905
[TBL] [Abstract][Full Text] [Related]
27. Embelin suppresses STAT3 signaling, proliferation, and survival of multiple myeloma via the protein tyrosine phosphatase PTEN.
Heo JY; Kim HJ; Kim SM; Park KR; Park SY; Kim SW; Nam D; Jang HJ; Lee SG; Ahn KS; Kim SH; Shim BS; Choi SH; Ahn KS
Cancer Lett; 2011 Sep; 308(1):71-80. PubMed ID: 21565443
[TBL] [Abstract][Full Text] [Related]
28. Matrix metalloproteinase-13 expression in IL-1β-treated chondrocytes by activation of the p38 MAPK/c-Fos/AP-1 and JAK/STAT pathways.
Lim H; Kim HP
Arch Pharm Res; 2011 Jan; 34(1):109-17. PubMed ID: 21468922
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-1 beta and transforming growth factor-beta 3 cooperate to activate matrix metalloproteinase expression and invasiveness in A549 lung adenocarcinoma cells.
Petrella BL; Armstrong DA; Vincenti MP
Cancer Lett; 2012 Dec; 325(2):220-6. PubMed ID: 22796605
[TBL] [Abstract][Full Text] [Related]
30. Impaired JAK2-induced activation of STAT3 in failing human myocytes.
Cambi GE; Lucchese G; Djeokeng MM; Modesti A; Fiaschi T; Faggian G; Sani G; Modesti PA
Mol Biosyst; 2012 Sep; 8(9):2351-9. PubMed ID: 22735740
[TBL] [Abstract][Full Text] [Related]
31. TGF-beta1 suppresses IL-6-induced STAT3 activation through regulation of Jak2 expression in prostate epithelial cells.
Starsíchová A; Lincová E; Pernicová Z; Kozubík A; Soucek K
Cell Signal; 2010 Nov; 22(11):1734-44. PubMed ID: 20603212
[TBL] [Abstract][Full Text] [Related]
32. Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: up-regulation of interleukin 10 and down-regulation of interleukin 12 production.
Huang M; Stolina M; Sharma S; Mao JT; Zhu L; Miller PW; Wollman J; Herschman H; Dubinett SM
Cancer Res; 1998 Mar; 58(6):1208-16. PubMed ID: 9515807
[TBL] [Abstract][Full Text] [Related]
33. PRDX6 promotes tumor development via the JAK2/STAT3 pathway in a urethane-induced lung tumor model.
Yun HM; Park KR; Park MH; Kim DH; Jo MR; Kim JY; Kim EC; Yoon DY; Han SB; Hong JT
Free Radic Biol Med; 2015 Mar; 80():136-44. PubMed ID: 25582888
[TBL] [Abstract][Full Text] [Related]
34. JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells.
Liu RY; Zeng Y; Lei Z; Wang L; Yang H; Liu Z; Zhao J; Zhang HT
Int J Oncol; 2014 May; 44(5):1643-51. PubMed ID: 24573038
[TBL] [Abstract][Full Text] [Related]
35. [Effect of JAK2/STAT3/vimentin signaling pathway on proliferation and migration of human colon cancer cells].
Xu JH; Zhang C; Tang B; Hao YX; Chen J; Liu T; Cui H
Zhonghua Wei Chang Wai Ke Za Zhi; 2010 Apr; 13(4):282-5. PubMed ID: 20422486
[TBL] [Abstract][Full Text] [Related]
36. [Influence on the cytokines expression on hepatic tissue by inhibition the signal pathway of inflammatory mediators following extensive hepatectomy in rats].
Mao YL; Yu Z; Sang XT; Lu X; Yang ZY; Zhong SX
Zhonghua Wai Ke Za Zhi; 2005 Jan; 43(1):6-9. PubMed ID: 15774164
[TBL] [Abstract][Full Text] [Related]
37. C/EBPdelta is a downstream mediator of IL-6 induced growth inhibition of prostate cancer cells.
Sanford DC; DeWille JW
Prostate; 2005 May; 63(2):143-54. PubMed ID: 15486993
[TBL] [Abstract][Full Text] [Related]
38. Epidermal growth factor-induced ovarian carcinoma cell migration is associated with JAK2/STAT3 signals and changes in the abundance and localization of alpha6beta1 integrin.
Colomiere M; Findlay J; Ackland L; Ahmed N
Int J Biochem Cell Biol; 2009 May; 41(5):1034-45. PubMed ID: 18930836
[TBL] [Abstract][Full Text] [Related]
39. Concanavalin-A triggers inflammatory response through JAK/STAT3 signalling and modulates MT1-MMP regulation of COX-2 in mesenchymal stromal cells.
Akla N; Pratt J; Annabi B
Exp Cell Res; 2012 Nov; 318(19):2498-506. PubMed ID: 22971618
[TBL] [Abstract][Full Text] [Related]
40. Interleukin 23 regulates proliferation of lung cancer cells in a concentration-dependent way in association with the interleukin-23 receptor.
Li J; Zhang L; Zhang J; Wei Y; Li K; Huang L; Zhang S; Gao B; Wang X; Lin P
Carcinogenesis; 2013 Mar; 34(3):658-66. PubMed ID: 23250909
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
